Get more information about the market: https://www.imarcgroup.com/dry-eye-syndrome-market The global dry eye syndrome market size reached US$ 3.5 Billion in 2018. On account of these factors, the market value is projected to reach US$ 5.1 Billion by 2024, expanding at a CAGR of around 6.5% during 2019-2024. Want more information about this market? Request a free report sample: https://www.imarcgroup.com/dry-eye-syndrome-market/requestsample For India market research reports, visit: http://www.marketresearchindia.co.in Browse Related Report Cardiac Biomarkers Market Report: https://www.imarcgroup.com/cardiac-biomarkers-market Stem Cell Banking Market Report: https://www.imarcgroup.com/stem-cell-banking-market Contact Us IMARC Group James Smith Email: Sales@imarcgroup.com Tel No:(D) +91 120 433 0800 | https://www.imarcgroup.com Americas :- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 Linkedin: https://www.linkedin.com/company/imarc-group

1. Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global Dry Eye
Syndrome Market
Research Report
and Forecast 2024
Report Edition: 2019
© 2019 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group
The International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all sectors
and regions to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.

3. Report DescriptionReport Description and Highlights
Global Dry Eye Syndrome Market Overview:
As per the latest report by IMARC Group, titled “Dry Eye Syndrome Market: Global Industry Trends,
Share, Size, Growth, Opportunity and Forecast 2019-2024”, the global dry eye syndrome market size
reached US$ 3.5 Billion in 2018. Dry eye syndrome, also known as keratoconjunctivitis sicca (KCS),
refers to a condition in which the patient experiences a lack of lubrication or moisture on the surface of
their eyes. The symptoms include aching and burning sensations, soreness, redness, fatigue, and
itching in the eyes, along with photophobia. Moreover, watery eyes can also be a symptom of this
condition as the dry eye surface can over-stimulate the production of the watery component of tears
to reduce dryness.
Dry Eye Syndrome Market Trends
Reliance on electronic gadgets like computers and smartphones is one of the primary factors increasing
the prevalence of dry eye syndrome. Prolonged usage of these devices results in strained eyes,
diminished visual alertness, and mucosal dryness or burning sensation. Additionally, continuous staring
at these devices can decrease the stability of the tear film and cause ocular discomfort. As per
statistics, approximately 425-430 million individuals around the world get affected by diabetes.

4. Report DescriptionReport Description and Highlights
120.2
125.5 130.8 136.1 141.4 146.7 152.0 157.3
0
20
40
60
80
100
120
140
160
2011 2012 2013 2014 2015 2016 2017 2018
inBillionUS$
160.0 165.3 170.6 175.9 181.2 186.5
0
20
40
60
80
100
120
140
160
180
2019 2020 2021 2022 2023 2024
InBillionUS$
It causes constant changes in the composition of the patient’s blood, thereby adversely affecting their
tear glands. On account of these factors, the market value is projected to reach US$ 5.1 Billion by 2024,
expanding at a CAGR of around 6.5% during 2019-2024.
Request for a free sample report: https://www.imarcgroup.com/dry-eye-syndrome-
market/requestsample

5. Report DescriptionReport Description and Highlights
Apart from this, numerous diseases, such as diabetes, thyroid disorders, Sjogren’s syndrome, lupus,
scleroderma and rheumatoid arthritis, increase the chances of developing dry eyes among patients.
For more information, click here: https://www.imarcgroup.com/dry-eye-syndrome-market
Key Market Segmentation:
Market Segmentation by Disease Type
• Evaporative Dry Eye Syndrome
• Aqueous Dry Eye Syndrome
Based on the disease type, the market has been bifurcated into evaporative and aqueous dry eye
syndrome. At present, evaporative dry eye syndrome represents the most common disease type.
Market Segmentation by Drug Type
• Lubricant Eye Drops
• Anti-inflammatory Drugs

6. Report Description
Report Description and Highlights
• Autologous Serum Eye Drops
On the basis of the drug type, the market has been segregated into lubricant eye drops, anti-
inflammatory drugs and autologous serum eye drops. Currently, anti-inflammatory drugs represent the
largest segment as they aid in reducing the ocular surface inflammation that is commonly associated
with dry eye syndrome.
Market Segmentation by Product
• Liquid Drops
• Gel
• Liquid Wipes
• Eye Ointment
• Others
Based on the product, the market has been segmented into liquid drops, gels, liquid wipes, eye
ointment and others. The report finds that liquid eye drops account for the majority of the total market
share.

7. Report DescriptionReport Description and Highlights
Market Segmentation by Distribution Channel
• Pharmacies
• Hospital Pharmacies
• Online Pharmacies
The market has been analyzed on the basis of the distribution channel into retail, hospital and online
pharmacies. Amongst these, hospital pharmacies exhibit a clear dominance in the market.
Market Segmentation by Region
• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America
Region-wise, North America is the largest market for dry eye syndrome owing to the large patient pool,

8. Report DescriptionReport Description and Highlights
an increase in the usage of digital devices and the presence of several key players in the region. Other
major markets include Asia Pacific, Latin America, Middle East and Africa and Europe.
Competitive Landscape:
The competitive landscape of the market has also been examined with some of the key players.
• Novartis AG
• Allergan plc.
• Otsuka Holdings Co., Ltd.
• Santen Pharmaceutical Co., Ltd.
• Nicox S.A.
• Auven Therapeutics
• Akorn, Inc.
• Bausch + Lomb
• Alimera Science
• GlaxoSmithKline plc

9. Report DescriptionReport Description and Highlights
Browse Related Report
Wound Care Biologics Market Report: https://www.imarcgroup.com/wound-care-biologics-market
H1N1 Vaccines Market Report: https://www.imarcgroup.com/h1n1-vaccines-market

10. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

11. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

12. Report DescriptionReport Description and Highlights
© 2019 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

13. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com
https://www.imarcgroup.com
Contact Us